Human papillomavirus vaccine decision-making in Da Nang, Vietnam: Perceived spousal and adolescent-parent concordance

Vaccine

Volumn 27, Issue 17, 2009, Pages 2367-2371

  Breitkopf, Carmen Radecki ^a   Pearson, Heidi C ^a   Dinh, Tri A ^b   Tran, Bich Chieu T ^a   Vu, Thao ^a   Phan, G A Bao ^c   Ngo, Quang V ^d   Tran, Vinh D ^c   Rosenthal, Susan L ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c Da Nang General Hospital   (Viet Nam)

^d Da Nang Center for Reproductive Health Care   (Viet Nam)

Author keywords

Decision making; Developing countries; Human papillomavirus

Indexed keywords

WART VIRUS VACCINE;

ADULT; AGED; ARTICLE; CHILD PARENT RELATION; DECISION MAKING; DEMOGRAPHY; FEMALE; HEALTH CARE PERSONNEL; HUMAN; NORMAL HUMAN; PARENTAL ATTITUDE; PARENTAL CONSENT; PRIORITY JOURNAL; QUESTIONNAIRE; UTERINE CERVIX CANCER; VACCINATION; VIET NAM;

ADOLESCENT; ADULT; ATTITUDE TO HEALTH; DECISION MAKING; FEMALE; HEALTH EDUCATION; HUMANS; MALE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARENTS; PERCEPTION; QUESTIONNAIRES; SPOUSES; VIETNAM; YOUNG ADULT;

EID: 62249165774     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.02.021     Document Type: Article

References (24)

1. Ferlay J., Bray F., Pisani P., and Parkin D.M. GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5. Version 2. 0 (2004), IARC Press, Lyon
2. Suba E.J., Hung N.C., Duc N.B., and Raab S.S. De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the socialist republic of Vietnam. Cancer 91 (2001) 928-939
3. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Summary report on HPV and cervical cancer statistics in Viet Nam; 2007 [accessed 06/27/2008]. Available at http://www.who.int/hpvcentre.
4. Garland S.M., Hernandez-Avila M., Wheeler C.M., Perez G., Harper D.M., Leodolter S., et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 356 (2007) 928-943
5. Harper D.M., Franco E.L., Wheeler C.M., Moscicki A.B., Romanowski B., Roteli-Martins C.M., et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 367 (2006) 1247-1255
6. Mao C., Koutsky L.A., Ault K.A., Wheeler C.M., Brown D.R., Wiley D.J., et al. Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia. Obstet Gynecol 107 (2006) 18-27
7. The Future II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 356 (2007) 1927
8. Paavonen J., Jenkins D., Bosch F.X., Naud P., Salmeron J., Wheeler C.M., et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 369 (2007) 2161-2170
9. Villa L.L., Ault K.A., Guiliano A.R., Costa R.L., Petta C.A., Andrade R.P., et al. Immunologic responses following administration of a vaccine targeting human papillomavirus types 6, 11, 16 and 18. Vaccine 24 (2006) 5571-5583
10. Villa L.L., Costa R.L.R., Petta C.A., Andrade R.P., Paavonen J., Iversen O.-E., et al. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 LI virus-like particle vaccine through 5 years of follow-up. Br J Cancer 95 (2006) 1459-1466
11. PATH 2008. A vaccine for women's health: preparing the way for a new tool in the fight against cervical cancer; 2008 [accessed 06/19/2008]. Available at www.path.org/projects/cervical_cancer_vaccine.php.
12. PATH 2008. Introducing a vaccine to prevent cervical cancer in Vietnam; 2008 [accessed 06/19/2008]. Available at http://www.rho.org/files/PATH_Vietnam_CC_vaccine_proj_factsheet.pdf.
13. Kane M.A., Sherris J., Coursaget P., Aguado T., and Cutts F. Chapter 15: HPV vaccine use in the developing world. Vaccine 24S3 (2006) S3/132-S3/139
14. Zimet G.D., Perkins S.M., Sturm L.A., Bair R.M., Juliar B.E., and Mays R.M. Predictors of STI vaccine acceptability among parents and their adolescent children. J Adolesc Health 37 (2005) 179-186
15. Rosenthal S.L., Kottenhahn R.K., Biro F.M., and Succop P.A. Hepatitis B vaccine acceptance among adolescents and their parents. J Adolesc Health 17 (1995) 248-254
16. Zimet G.D., Liddon N., Rosenthal S.L., Lazcano-Ponce E., and Allen B. Chapter 24: Psychosocial aspects of vaccine acceptability. Vaccine 24S3 (2006) S3/201-S3/209
17. Dinh T., Rosenthal S.L., Doan E.D., Trang T., Pham V.H., Tran B.D., et al. Attitudes of mothers in Da Nang Vietnam toward a human papillomavirus vaccine. J Adolesc Health 40 (2007) 559-563
18. Slomovitz B.M., Sun C.C., Frumovitz M., Soliman P.T., Schmeler K.M., Pearson H.C., et al. Are women ready for the HPV vaccine?. Gynecol Oncol 103 (2006) 151-154
19. Liddon N., Pulley L., Cockerham W.C., Lueschen G., Vermund S.H., and Hook E.W. Parents'/guardians' willingness to vaccinate their children against genital herpes. J Adolesc Health 37 (2005) 187-193
20. Davidson A.R. From attitudes to actions to attitude change: the effects of amount and accuracy of information. In: Petty R.E., and Krosnick J.A. (Eds). Attitude strength: antecedents and consequences (1995), Lawrence Erlbaum Associates, Mahwah, NJ 315-336 [chapter 12]
21. Brabin L., Roberts S.A., Farzaneh F., and Kitchener H.C. Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes. Vaccine 24 (2006) 3087-3094
22. Toffolon-Weiss M., Hagan K., Leston J., Peterson L., Provost E., and Hennessy T. Alaska native parental attitudes on cervical cancer HPV and the HPV vaccine. Int J Circumpolar Health 67 (2008) 363-373
23. Mays R.M., Sturm L.A., and Zimet G.D. Parental perspectives on vaccinating children against sexually transmitted infections. Soc Sci Med 58 (2004) 1405-1413
24. Garfield C.F., and Isacco A. Fathers and the well-child visit. Pediatrics 117 (2006) e637-e645